Login to Your Account

Aastrom Set To Start Pivotal Work On Stem Cell Therapy

By Aaron Lorenzo

Wednesday, May 9, 2007
Aastrom Biosciences Inc. received FDA clearance to begin a pivotal trial of its regenerative stem cell product in osteonecrosis of the femoral head. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription